PPARG Could Work as a Valid Therapeutic Strategy for the Treatment of Lung Squamous Cell Carcinoma

Figure 3

LSCC prognostic network interfered with PPARG. Genes in blue represent a decreased expression level from the mega-analysis using 12 LSCC datasets; entities in red represent an increased expression level. Entities highlighted in blue were literature implicated as the LSCC-inhibitors, while those highlighted in red were LSCC-promoters.